Fingerprint
Dive into the research topics of 'A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
J. J. Raizer*, P. Giglio, J. Hu, M. Groves, R. Merrell, C. Conrad, S. Phuphanich, V. K. Puduvalli, M. Loghin, N. Paleologos, Y. Yuan, D. Liu, A. Rademaker, W. K. Yung, B. Vaillant, J. Rudnick, M. Chamberlain, N. Vick, S. Grimm, I. W. Tremont-Lukats
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
44
Scopus
citations